Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Aggression × Carboplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 295 Breast Neoplasms 162 Lung Neoplasms 153 Ovarian Neoplasms 139 Triple Negative Breast Neoplasms 76 Fallopian Tube Neoplasms 67 Squamous Cell Carcinoma of Head and Neck 66 Small Cell Lung Carcinoma 57 Esophageal Neoplasms 47 Neoplasms 44 Carcinoma, Ovarian Epithelial 41 Head and Neck Neoplasms 40 Esophageal Squamous Cell Carcinoma 33 Prostatic Neoplasms 32 Uterine Cervical Neoplasms 29 Brain Neoplasms 29 Recurrence 28 Endometrial Neoplasms 28 Neoplasm Metastasis 27 Lymphoma, Large B-Cell, Diffuse 27 Lymphoma 26 Adenocarcinoma of Lung 25 Carcinoma, Squamous Cell 23 Central Nervous System Neoplasms 21 Lymphoma, Non-Hodgkin 19 Hodgkin Disease 19 Retinoblastoma 18 Neuroblastoma 18 Testicular Neoplasms 16 Stomach Neoplasms 16

Interventions

selinexor 1 pegfilgrastim 1 Topotecan 1 Rituximab 1 Prednisone 1 Positron Emission Tomography Computed Tomography 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Clofarabine 1 Carboplatin 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡